TY - JOUR
T1 - Asociación entre el antecedente de comorbilidades y el uso de medicina alternativa y complementaria para prevenir la COVID-19 en una región del norte del Perú
AU - Herrera-Añazco, Percy
AU - Toro-Huamanchumo, Carlos J.
AU - Nuñez-Tarazona, Wander
AU - Farfán-Zapata, Olenka
N1 - Publisher Copyright:
© 2024 Publicado por Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.
PY - 2024
Y1 - 2024
N2 - Objective: To evaluate the association between a history of comorbidities and the use of complementary and alternative medicine (CAM) to prevent COVID-19 in Lambayeque, Peru. Material and Methods: Analytical cross-sectional study that used information from the database of the Red Prestacional Lambayeque of the Social Security of Health. The outcome variable was the self-report of having consumed and/or used some type of MAC during the pandemic to prevent COVID-19. The main independent variable was the self-reported history of having any comorbidity. Sociodemographic and clinical confounding variables were included. To assess the association of interest, crude (PRc) and adjusted (PRa) prevalence ratios were calculated using Poisson regression models with robust variances. Results: A total of 243 participants with a history of COVID-19 were surveyed. Most were male (54.7%), and the median age was 29 [25-59] years. 29.2% used CAM to prevent COVID-19. In the adjusted model, a history of comorbidity increased the probability of CAM use (PR: 1.55; 95% CI: 1.05 – 2.28; p: 0.028). Conclusions: A history of comorbidity was associated with a higher probability of CAM consumption during the COVID-19 pandemic in adults to prevent SARS-CoV-2 infection.
AB - Objective: To evaluate the association between a history of comorbidities and the use of complementary and alternative medicine (CAM) to prevent COVID-19 in Lambayeque, Peru. Material and Methods: Analytical cross-sectional study that used information from the database of the Red Prestacional Lambayeque of the Social Security of Health. The outcome variable was the self-report of having consumed and/or used some type of MAC during the pandemic to prevent COVID-19. The main independent variable was the self-reported history of having any comorbidity. Sociodemographic and clinical confounding variables were included. To assess the association of interest, crude (PRc) and adjusted (PRa) prevalence ratios were calculated using Poisson regression models with robust variances. Results: A total of 243 participants with a history of COVID-19 were surveyed. Most were male (54.7%), and the median age was 29 [25-59] years. 29.2% used CAM to prevent COVID-19. In the adjusted model, a history of comorbidity increased the probability of CAM use (PR: 1.55; 95% CI: 1.05 – 2.28; p: 0.028). Conclusions: A history of comorbidity was associated with a higher probability of CAM consumption during the COVID-19 pandemic in adults to prevent SARS-CoV-2 infection.
KW - Complementary Therapies
KW - Coronavirus Infections
KW - Medicine Traditional
KW - Plants Medicinal
KW - Primary Prevention (DeCS)
UR - http://www.scopus.com/inward/record.url?scp=85197219339&partnerID=8YFLogxK
U2 - 10.35434/rcmhnaaa.2024.171.2046
DO - 10.35434/rcmhnaaa.2024.171.2046
M3 - Artículo
AN - SCOPUS:85197219339
SN - 2225-5109
VL - 17
JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
IS - 1
ER -